(Q41687493)

7 October 2017

1 reference

title

Genotoxic activity of praziquantel (English)

1 reference

7 October 2017

1 reference

Montero R

1

1 reference

7 October 2017

Ostrosky P

series ordinal

2

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

7 October 2017

1 reference

7 October 2017

volume

387

1 reference

7 October 2017

issue

3

1 reference

7 October 2017

page(s)

123-139

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 October 2017

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

1 reference

7 January 2021

Absence of mutagenicity of praziquantel, a new, effective, anti-schistosomal drug, in bacteria, yeasts, insects and mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Mutagenicity studies with Praziquantel, a new anthelmintic drug, in mammalian systems

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Mutagenicity studies with praziquantel, a new anthelmintic drug: Tissue-, host-, and urine-mediated mutagenicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Enhancement of benzene clastogenicity by praziquantel in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Mutation at the HPRT locus in patients with neurocysticercosis treated with praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 18. Review of the genotoxicity and carcinogenicity of antischistosomal drugs; is there a case for a study of mutation epidemiology? Report

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Praziquantel for the treatment of Diphyllobothrium nihonkaiense infections in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Activity of praziquantel (0.5 mg kg-1) against Anoplocephala perfoliata (Cestoda) in equids

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Efficacy of pyrantel embonate and praziquantel against the equine tapeworm Anoplocephaloides mamillana

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Use of praziquantel for the control of Moniezia expansa in lambs

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Registration of generic alternatives to praziquantel for the control of Taenia ovis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Effects of praziquantel on experimental Schistosoma bovis infection in goats

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Efficacy of praziquantel in natural populations of mallards infected with avian schistosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Antigen detection assay to monitor the efficacy of praziquantel for treatment of Paragonimus westermani infections

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Praziquantel treatment normalizes intestinal myoelectric alterations associated with Hymenolepis diminuta-infected rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Effects of free and liposomized praziquantel on worm burden and antibody response in mice infected with Mesocestoides corti tetrathyridia

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Metabolism studies of the antischistosomal drug praziquantel using tandem mass spectrometry: distribution of parent drug and ten metabolites obtained from control and schistosome-infected mouse urine

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Praziquantel in the cerebrospinal fluid in neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Praziquantel treatment of brain and muscle porcine Taenia solium cysticercosis. 2. Immunological and cytogenetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Physiochemical interactions of praziquantel, oxamniquine and tablet excipients

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Lethal effect of oxamniquine and praziquantel on mice experimentally infected with Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Effects of phenobarbital and 3-methylcholanthrene pretreatment on the pharmacokinetics of praziquantel in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Light and scanning electron microscopy studies on the effects of the enantiomers of praziquantel and its main metabolite on Schistosoma mansoni in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Repeated exposure to Opisthorchis viverrini and treatment with the antihelminthic Praziquantel lacks carcinogenic potential

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Evaluation of the carcinogenic and genotoxic potential of praziquantel in the Syrian hamster embryo cell transformation assay

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Relationship between genotype and function of the human CYP1A1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Functional significance of different human CYP1A1 genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Genotoxic effects of metronidazole

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

No cytogenic effect of metronidazole

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Cytochrome P4502A5 expression and inducibility by phenobarbital is modulated by cAMP in mouse primary hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Altered generation of interleukin 1 in chronic human schistosomiasis mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

T cell phenotype alterations in hepatosplenic schistosomiasis mansoni normalize after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Altered behaviour of carbohydrate-bound molecules and lipids in areas of the tegument of adult Schistosoma mansoni worms damaged by praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Schistosoma mansoni: molecular cloning and sequencing of the 200-kDa chemotherapeutic target antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Praziquantel: physiological evidence for its site(s) of action in magnesium-paralysed Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Schistosoma mansoni: praziquantel-induced tegumental lesion exposes actin of surface spines and allows binding of actin depolymerizing factor, gelsolin

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Autoantibodies and the physiological role of immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Efficacy of treatment of murineSchistosoma mansoniinfections with praziquantel and oxamniquine correlates with infection intensity: role of host antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Active immunization of mice with Schistosoma mansoni worm membrane antigens enhances efficacy of praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Time-dependent modulation of liver lesion development in Opisthorchis-infected Syrian hamster by an antihelminthic drug, praziquantel.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Praziquantel in the treatment of neurocysticercosis: long-term follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. 1. Radiological, physiological and histopathological studies

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Clinical study evaluating efficacy of praziquantel in clonorchiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Clinical and pharmacokinetic study of praziquantel in Egyptian schistosomiasis patients with and without liver cell failure

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Plasma levels of praziquantel decrease when dexamethasone is given simultaneously.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

In vitro induction of micronuclei in lymphocytes: the use of bromodeoxyuridine as a proliferation marker

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Perspectives on the control of Taenia solium

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Praziquantel (antischistosomal drug): is it clastogenic, co-clastogenic or anticlastogenic?

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Reduction in chromosomal damage in schistosomiasis patients after treatment with praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Promotion of Rat Hepatocarcinogenesis by Praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Risk identification using structural concepts: the potential carcinogenicity of praziquantel.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Induction of chromosome loss in Saccharomyces cerevisiae strain D61.M by selected benzimidazole compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Reduction in tissue egg load and maintenance of resistance to challenge in mice infected with Schistosoma mansoni, following combined treatment with praziquantel and an antifibrotic agent.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Attempts to induce resistance in mice to Schistosoma japonicum and Schistosoma mansoni by exposure to crude schistosome antigens plus cloned glutathione-S-transferases.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

Lack of modulation effects of praziquantel on DMN-induced lesion development in the Syrian hamster liver

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2897%2900027-6

7 January 2021

10.1016/S1383-5742(97)00027-6

Identifiers

DOI

1 reference

release_6folhzhz7nfuzj2hgrmiaucngu

7 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6folhzhz7nfuzj2hgrmiaucngu

24 November 2022

mapped directly with Wikidata item

1 reference